Methylmethacrylate-sulfopropylmethacrylate nanoparticles with surface RMP-7 for targeting delivery of antiretroviral drugs across the blood-brain barrier

Colloids and Surfaces B: Biointerfaces

Volumn 90, Issue 1, 2012, Pages 75-82

  Kuo, Yung Chih ^a   Lee, Chin Lung ^a  

^a NATIONAL CHUNG CHENG UNIVERSITY   (Taiwan)

Author keywords

Blood brain barrier; Endocytosis; Methylmethacrylate sulfopropylmethacrylate; Nanoparticles; RMP 7; Tight junction

Indexed keywords

BLOOD-BRAIN BARRIER; ENDOCYTOSIS; METHYLMETHACRYLATE-SULFOPROPYLMETHACRYLATE; RMP-7; TIGHT JUNCTIONS;

AMMONIUM COMPOUNDS; CELL CULTURE; ENDOTHELIAL CELLS; MOLECULAR BIOLOGY; NANOPARTICLES; TOPOGRAPHY;

BLOOD;

DELAVIRDINE; INORGANIC SALT; LOBRADIMIL; METHYLMETHACRYLATE SULFOPROPYLMETHACRYLATE NANOPARTICLE; NANOPARTICLE; PERSULFATE AMMONIUM; SAQUINAVIR; STAVUDINE; UNCLASSIFIED DRUG;

ARTICLE; ASTROCYTE; ATOMIC FORCE MICROSCOPY; BLOOD BRAIN BARRIER; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG PENETRATION; ENDOCYTOSIS; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; MORPHOLOGY; PARTICLE SIZE; POLYMERIZATION; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY;

AMMONIUM SULFATE; ANTI-HIV AGENTS; ASTROCYTES; BIOLOGICAL TRANSPORT; BLOOD-BRAIN BARRIER; BRADYKININ; CELLS, CULTURED; COCULTURE TECHNIQUES; DELAVIRDINE; DRUG CARRIERS; ENDOTHELIAL CELLS; HIV; HIV INFECTIONS; HUMANS; KINETICS; METHACRYLATES; MICROSCOPY, ELECTRON, SCANNING; MOLECULAR TARGETED THERAPY; NANOPARTICLES; PARTICLE SIZE; PERMEABILITY; SAQUINAVIR; STAVUDINE;

EID: 82355190193     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2011.09.048     Document Type: Article

References (55)

1. Sharma P., Ganta S., Denny W.A., Garg A. Formulation and pharmacokinetics of lipid nanoparticles of a chemically sensitive nitrogen mustard derivative: chlorambucil. Int. J. Pharm. 2009, 367:187-194.
2. Y.C. Kuo, P.I. Lin, C.C. Wang, Targeting nevirapine delivery across human brain microvesscular endothelial cells using transferrin-grafted poly(lactide-co-glycolide) nanoparticles, Nanomedicine. in press. doi:10.2217/nnm.11.25.
3. Heurtault B., Saulnier P., Pech B., Proust J.E., Benoit J.P. Physico-chemical stability of colloidal lipid particles. Biomaterials 2003, 24:4283-4300.
4. Manjunath K., Venkateswarlu V. Pharmacokinetics, tissue distribution and bioavailability of clozapine solid lipid nanoparticles after intravenous and intraduodenal administration. J. Control. Release 2005, 107:215-228.
5. Couvreur P., Kante B., Roland M., Guiot P., Bauduin P. Polycyanoacrylate nanoparticles as potential lysosomotropic carrier: preparation, morphological and sorptive properties. J. Pharm. Pharmacol. 1982, 31:331-332.
6. Kriwet B., Tucker C.J., Kalantar T.H., Green D.P. Synthesis of bioadhensive poly(acrylic acid) nano- and microparticles using an inverse emulsion polymerization method for the entrapment of hydrophilic drug candidates. J. Control. Release 1998, 56:149-158.
7. Stenekes R.J.H., Loebis A.E., Fernandes C.M., Crommelin D.J.A., Hennick W.E. Controlled release of liposomes from biodegradable dextran microspheres: a novel delivery concept. Pharm. Res. 2000, 17:690-695.
8. Kuo Y.C., Kuo C.Y. Electromagnetic interference in the permeability of saquinavir across the blood-brain barrier using nanoparticulate carriers. Int. J. Pharm. 2008, 351:271-281.
9. Kuo Y.C., Chen H.H. Effect of electromagnetic field on endocytosis of cationic solid lipid nanoparticles by human brain-microvascular endothelial cells. J. Drug Target. 2010, 18:447-456.
10. Couvreur P., Kante B., Grislain L., Roland M., Spesiser P. Toxicity of polyalkylcyanoacrylate nanoparticles II: doxorubicin-loaded nanoparticles. J. Pharm. Sci. 1982, 7:790-792.
11. Kuo Y.C., Liang C.T. Inhibition of human brain malignant glioblastoma cells using carmustine-loaded catanionic solid lipid nanoparticles with surface anti-epithelial growth factor receptor. Biomaterials 2011, 32:3340-3350.
12. Kuo Y.C., Liang C.T. Catanionic solid lipid nanoparticles carrying doxorubicin for inhibiting the growth of U87MG cells. Colloids Surf. B 2011, 85:131-137.
13. Damge C., Michel C., Aprahamian M., Couvreur P., Devissaguet J.P. Nanocapsules as carriers for oral peptide delivery. J. Pharm. Pharmacol. 1990, 31:233-239.
14. Calvo P., Sanchez A., Martinez J., Lopez M.I., Calonge M., Pastor J.C., Alonso M.J. Polyester nanocapsules as new topical ocular delivery systems for cyclosporine A. Pharm. Res. 1996, 13:311-315.
15. Cho K., Wang X., Nie S., Chen Z., Shin D.M. Therapeutic nanoparticles for drug delivery in cancer. Clin. Cancer Res. 2008, 14:1310-1316.
16. Kuo Y.C., Chen H.H. Entrapment and release of saquinavir using novel cationic solid lipid nanoparticles. Int. J. Pharm. 2009, 365:206-213.
17. Kuo Y.C., Yu H.W. Polyethyleneimine/poly-(γ-glutamic acid)/poly(lactide-co-glycolide) nanoparticles for loading and delivering antiretroviral drug. Colloids Surf. B 2011, 88:158-164.
18. Kreuter J. Nanoparticle systems for brain delivery of drugs. Adv. Drug Deliv. Rev. 2001, 47:68-81.
19. Kuo Y.C., Yu H.W. Transport of saquinavir across human brain-microvascular endothelial cells by poly(lactide-co-glycolide) nanoparticles with surface poly-(γ-glutamic acid). Int. J. Pharm. 2011, 416:365-375.
20. Rolland A., Begue J.M., Le Verge R., Guillouzo A. Increase of doxorubicin penetration in cultured rat hepatocytes by its binding to polymethacrylic nanoparticles. Int. J. Pharm. 1989, 53:67-73.
21. Hoffmann F., Cinatl J., Kabickova H., Cinatl J., Kreuter J., Stieneker F. Preparation, characterization and cytoxicity of methylmethacrylate copolymer nanoparticles with a permanent positive surface charge. Int. J. Pharm. 1997, 157:189-198.
22. Langer K., Marburger C., Berthold A., Kreuter J., Stieneker F. Methylmethacrylate sulfopropylmethacrylate copolymer nanoparticles for drug delivery. Part I. Preparation and physicochemical characterization. Int. J. Pharm. 1996, 137:67-74.
23. Langer K., Stieneker F., Lambrecht G., Mutschler E., Kreuter J. Methylmethacrylate sulfopropylmethacrylate copolymer nanoparticles for drug delively. Part II. Arecaidine propargly ester and pilocarpine loading and in vitro release. Int. J. Pharm. 1997, 158:211-217.
24. Kuo Y.C. Loading efficiency of stavudine on polybutylcyanoacrylate and methylmethacrylate-sulfopropylmethacrylate copolymer nanoparticles. Int. J. Pharm. 2005, 290:161-172.
25. Langer K., Mutschler E., Lambrecht G., Mayer D., Troschau G., Stieneker F., Kreuter J. Methylmethacrylate sulfopropylmethacrylate copolymer nanoparticles for drug delivery. Part III. Evaluation as drug delivery system for ophthalmic applications. Int. J. Pharm. 1997, 158:219-231.
26. Kuo Y.C., Chen H.H. Effect of nanoparticulate polybutylcyanoacrylate and methylmethacrylate-sulfopropylmethacrylate on the permeability of zidovudine and lamivudine across the in vitro blood-brain barrier. Int. J. Pharm. 2006, 327:160-169.
27. Elliott P.J., Hayward N.J., Dean R.L., Blunt D.G., Bartus R.T. Intravenous RMP-7 selectively increases uptake of carboplatin into rat brain tumors. Cancer Res. 1996, 56:3998-4005.
28. Emerich D.F., Dean R.L., Marsh J., Pink M., Lafreniere D., Snodgrass P., Bartus R.T. Intravenous Cereport (RMP-7) enhances delivery of hydrophilic chemotherapeutics and increases survival in rats with metastatic tumors in the brain. Pharm. Res. 2000, 17:1212-1219.
29. Emerich D.F., Snodgrass P., Pink M., Bloom F., Bartus R.T. Central analgesic actions of loperamide following transient permeation of the blood brain barrier with Cereporte™ (RMP-7). Brain Res. 1998, 801:259-266.
30. Zhang X., Xie Y., Jin Y., Hou X., Ye L., Lou J. The effect of RMP-7 and its derivative on transporting Evens blue liposomes into the brain. Drug Deliv. 2004, 11:301-309.
31. Kuo Y.C., Yu H.W. Expression of ornithine decarboxylase during the transport of saquinavir across the blood-brain barrier using composite polymeric nanocarriers under an electromagnetic field. Colloids Surf. B 2011, 88:627-634.
32. Kuo Y.C., Chung J.F. Physicochemical properties of nevirapine-loaded solid lipid nanoparticles and nanostructured lipid carriers. Colloids Surf. B 2011, 83:299-306.
33. Kuo Y.C., Chen I.C. Evaluation of surface charge density and surface potential by electrophoretic mobility for solid lipid nanoparticles and human brain-microvascular endothelial cells. J. Phys. Chem. B 2007, 111:11228-11236.
34. Kuo Y.C., Lu C.H. Effect of human astrocytes on the characteristics of human brain-microvascular endothelial cells in the blood-brain barrier. Colloids Surf. B 2011, 86:225-231.
35. Kuo Y.C., Lu C.H. Regulation of endocytosis into human brain-microvascular endothelial cells by inhibition of efflux proteins. Colloids Surf. B 2011, 87:139-145.
36. Kuo Y.C., Chiu K.H. Inverted colloidal crystal scaffolds with laminin-derived peptides for neuronal differentiation of bone marrow stromal cells. Biomaterials 2011, 32:819-831.
37. Kuo Y.C., Chung C.Y. Solid lipid nanoparticles comprising internal Compritol 888 ATO, tripalmitin and cacao butter for encapsulating and releasing stavudine, delavirdine and saquinavir. Colloids Surf. B 2011, 88:682-690.
38. Kuo Y.C., Su F.L. Transport of stavudine, delavirdine, and saquinavir across the blood-brain barrier by polybutylcyanoacrylate, methylmethacrylate-sulfopropylmethacrylate, and solid lipid nanoparticles. Int. J. Pharm. 2007, 340:143-152.
39. Straub J.A., Akiyama A., Parmar P. In vitro plasma metabolism of RMP-7. Pharm. Res. 1994, 11:1673-1676.
40. Doctrow S.R., Abelleira S.M., Curry L.A., Heller-Harrison R., Kozarich J.W., Malfroy B., McCarroll L.A., Morgan K.G., Morrow A.R., Musso G.F., Smart J.L., Straub J.A., Turnbull B., Gloff C.A. The bradykinin analog RMP-7 increases intracellular free calcium levels in rat brain microvascular endothelial cells. J. Pharmacol. Exp. Ther. 1994, 271:229-237.
41. Unterberg A., Wahl M., Baethmann A. Effects of bradykinin on permeability and diameter of pial vessels in vivo. J. Cereb. Blood Flow Metab. 1984, 4:574-585.
42. Wysolmerski R.B., Lagunoff D. Involvement of myosin light chain kinase in endothelial cell retraction. Proc. Natl. Acad. Sci. U.S.A. 1990, 87:16-20.
43. Morel N.M.L., Petruzzo P.P., Hechtman H.B., Shepro D. Inflammatory agonists that increase microvascular permeability in vivo stimulate cultured pulmonary microvessel endothelial cell contraction. Inflammation 1990, 14:571-583.
44. Wahl M., Unterberg A., Baethmann A., Schilling L. Mediators of blood-brain barrier dysfunction and formation of vasogenic brain edema. J. Cereb. Blood Flow Metab. 1988, 8:621-634.
45. Inamura T., Nomura R., Black K.L. Intracarotid infusion of RMP-7, a method for selective drug delivery to brain tumors. J. Neurosurg. 1994, 81:752-758.
46. Sanovich E., Bartus R.T., Friden P.M., Dean R.L., Le H.Q., Brightman M.W. Pathway across blood-brain barrier opened by the bradykinin agonist, RMP-7. Brain Res. 1995, 705:125-135.
47. Bundgaard M. Ultrastructure of frog cerebral and pial microvessels and their impermeability to lanthanum ions. Brain Res. 1982, 241:57-65.
48. Ford J., Osborn C., Barton T., Bleehen N.M. A phase I study of intravenous RMP-7 with carboplatin in patients with progression of malignant glioma. Eur. J. Cancer 1998, 34:1807-1811.
49. LeMay D.R., Kittaka M., Gordon E.M., Gray B., Stins M.F., McComb J.G., Jovanovic S., Tabrizi P., Weiss M.H., Bartus R., Anderson W.F., Zlokovic B.V. Intravenous RMP-7 increases delivery of Ganciclovir into rat brain tumors and enhances the effects of herpes simplex virus thymidine kinase gene therapy. Hum. Gene Ther. 1998, 9:989-995.
50. Elliot P.J., Mackic J.B., Graney W.F., Bartus R.T., Zlokovic B.V. RMP-7, a bradykinin agonist. Increases permeability of blood-ocular barriers in the guinea pig. Invest. Ophthalmol. Vis. Sci. 1995, 36:2542-2547.
51. Elliot P.J., Bartus R.T., Mackic J.B., Zlokovic B.V. Intravenous infusion of RMP-7 increases ocular uptake of ganciclovir. Pharm. Res. 1997, 14:80-85.
52. ®: evidence for a sensitive, autoregulated, receptor-mediated system. Immunopharmacology 1996, 33:270-278.
53. Pizard A., Blaukat A., Muller-Esterl W., Alhenc-Gelas F., Rajerison R.M. Bradykinin-induced internalization of the human B2 receptor requires phosphorylation of three serine and two threonine residues at its carboxyl tail. J. Biol. Chem. 1999, 274:12738-12747.
54. Liu Y., Hashizume K., Chen Z., Samoto K., Ningaraj N., Asotra K., Black K.L. Correlation between bradykinin induced blood-tumor barrier permeability and B2 receptor expression in experimental brain tumors. Neurol. Res. 2001, 23:379-387.
55. Cloughesy T.F., Black K.L. Pharmacological blood-brain barrier modification for selective drug delivery. J. Neurooncol. 1995, 26:125-132.